Dr. Nina T Gentile, MD
Claim this profileTemple University Hospital
Area of expertise
Stroke
Nina T Gentile, MD has run 4 trials for Stroke.
Coronavirus
Nina T Gentile, MD has run 3 trials for Coronavirus. Some of their research focus areas include:
Affiliated Hospitals
Temple University Hospital
Temple University
Clinical Trials Nina T Gentile, MD is currently running
TS23
for Stroke
SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in acute ischemic stroke.
Recruiting
0 awards
Phase 2
Recombinant Factor VIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include only those treated within 2 hours with a positive spot sign on a baseline CT angiogram.
Recruiting
1 award
Phase 3
2 criteria
More about Nina T Gentile, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Nina T Gentile, MD has experience with
- Placebo
- Montelukast
- Therapeutic Hypothermia
- PillCam UGI
- Ivermectin
- Fluvoxamine
Breakdown of trials Nina T Gentile, MD has run
I Am A Healthy Volunteer
Brain Anoxia Ischemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nina T Gentile, MD specialize in?
Nina T Gentile, MD focuses on Stroke and Coronavirus. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Nina T Gentile, MD currently recruiting for clinical trials?
Yes, Nina T Gentile, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Nina T Gentile, MD has studied deeply?
Yes, Nina T Gentile, MD has studied treatments such as Placebo, Montelukast, Therapeutic Hypothermia.
What is the best way to schedule an appointment with Nina T Gentile, MD?
Apply for one of the trials that Nina T Gentile, MD is conducting.
What is the office address of Nina T Gentile, MD?
The office of Nina T Gentile, MD is located at: Temple University Hospital, Philadelphia, Pennsylvania 19140 United States. This is the address for their practice at the Temple University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.